Update Results of Paclitaxel and Cisplatin in Combination with Anlotinib As First-Line Regimen for Patients with Advanced ESCC: A Multicenter, Single-Arm, Open-Label Phase Ⅱ Clinical Trial.
Journal of Clinical Oncology（2023）
Key words
Radiotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined